Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
Crown Laboratories’ Acquisition of StriVectin
Indorama’s $1.3 Billion Acquisition of Ultrapar’s Chemical Unit
Lowenstein, Beccar Varela, and Mattos Filho, Veiga Filho, Marrey Jr. E Quiroga advised Indorama Ventures on the deal. Skadden, Stocche Forbes, BMA – Barbosa, Müssnich, Aragão...